Dalbavancin Injection, Powder, Lyophilized, For Solution
Product Images NDC 71288-034

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dalbavancin (NDC 71288-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Dalbavancin for Injection 500 mg Carton)

Principal Display Panel (Dalbavancin for Injection 500 mg Carton)
The text appears to be a label or description regarding Dalbavancin for Injection, with each entry providing details such as the content (500 mg per vial), administration instructions (for intravenous infusion only), and storage information. The product is presented as a sterile single-dose vial that should have any unused portion discarded. Additionally, the text includes some random characters and symbols that might be part of the packaging design or formatting.*
FDA Label Image

Figure 1 (Dalb Structure)

FDA Label Image

Principal Display Panel (Dalbavancin for Injection 500 mg Vial)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.